Table 1.
Characteristics of study subjects.
| Parameter | Non-OB | OB/BOS |
|---|---|---|
| Lung transplant diagnosis (n) | 21 | 13 |
| Emphysema | 6 | 4 |
| Pulmonary fibrosis | ||
| Idiopathic | 0 | 3 |
| Collagen vascular disease-associated | 4 | 1 |
| Cystic fibrosis | 2 | 2 |
| Pulmonary hypertension | ||
| Idiopathic PAH | 2 | 1 |
| Eisenmenger’s syndrome | 7 | 2 |
| Bilateral lung transplant | 10 | 6 |
| Post-op days to OB/BOS diagnosis* | N/A | 485 (73–2070) |
| Post-op day BALF obtained* | 335 (270–395) | 387 (45–2205) |
| Days BALF collected before OB/BOS* | N/A | 140 (60–365) |
Abbreviations: OB: obliterative bronchiolitis; BOS: bronchiolitis obliterans syndrome; BALF: bronchoalveolar lavage fluid.
*
Values expressed as median (range).